160 related articles for article (PubMed ID: 32804707)
1. Preliminary analysis of distinct clinical and biologic features of bone metastases in melanoma.
Wilson MA; Zhong J; Johannet P; Lee Y; Masub N; Wechter T; Moran U; Berman RS; Shapiro RL; Weber J; Pavlick A; Osman I
Melanoma Res; 2020 Oct; 30(5):492-499. PubMed ID: 32804707
[TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle and solitary bone metastases from malignant melanoma: multimodality imaging and oncological outcome.
Gómez-León N; Pacheco-Barcia V; Ballesteros AI; Fraga J; Colomer R; Friera A
Melanoma Res; 2018 Dec; 28(6):562-570. PubMed ID: 29975212
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic Features and Prognostic Factors of Primary Cutaneous Melanoma: a Multicenter Study in Korea.
Kim JE; Chung BY; Sim CY; Park AY; Lee JS; Whang KU; Park YL; Kim HO; Park CW; Lee SY
J Korean Med Sci; 2019 Apr; 34(16):e126. PubMed ID: 31020815
[TBL] [Abstract][Full Text] [Related]
4. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).
Balch CM; Soong SJ; Murad TM; Smith JW; Maddox WA; Durant JR
J Clin Oncol; 1983 Feb; 1(2):126-34. PubMed ID: 6668496
[TBL] [Abstract][Full Text] [Related]
5. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma.
Meier F; Will S; Ellwanger U; Schlagenhauff B; Schittek B; Rassner G; Garbe C
Br J Dermatol; 2002 Jul; 147(1):62-70. PubMed ID: 12100186
[TBL] [Abstract][Full Text] [Related]
6. Clinical correlates and prognostic value of different metastatic sites in patients with malignant melanoma of the skin: a SEER database analysis.
Abdel-Rahman O
J Dermatolog Treat; 2018 Mar; 29(2):176-181. PubMed ID: 28745581
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in 1,521 melanoma patients with distant metastases.
Barth A; Wanek LA; Morton DL
J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for development of melanoma brain metastasis and disease progression: a single-center retrospective analysis.
Gardner LJ; Ward M; Andtbacka RHI; Boucher KM; Bowen GM; Bowles TL; Cohen AL; Grossmann K; Hitchcock YJ; Holmen SL; Hyngstrom J; Khong H; McMahon M; Monroe MM; Ross CB; Suneja G; Wada D; Grossman D
Melanoma Res; 2017 Oct; 27(5):477-484. PubMed ID: 28800031
[TBL] [Abstract][Full Text] [Related]
9. Disease progression in patients with thin cutaneous melanomas (tumour thickness < or = 0.75 mm): clinical and epidemiological data from the Tumour Center Munich 1977-98.
Schmid-Wendtner MH; Baumert J; Eberle J; Plewig G; Volkenandt M; Sander CA
Br J Dermatol; 2003 Oct; 149(4):788-93. PubMed ID: 14616371
[TBL] [Abstract][Full Text] [Related]
10. Favorable prognosis for malignant melanomas associated with acquired melanocytic nevi.
Friedman RJ; Rigel DS; Kopf AW; Lieblich L; Lew R; Harris MN; Roses DF; Gumport SL; Ragaz A; Waldo E; Levine J; Levenstein M; Koenig R; Bart RS; Trau H
Arch Dermatol; 1983 Jun; 119(6):455-62. PubMed ID: 6859885
[TBL] [Abstract][Full Text] [Related]
11. Endobronchial metastases from melanoma: a survival analysis.
Chaussende A; Hermant C; Tazi-Mezalek R; Favrolt N; Hureaux J; Fournier C; Lorut C; Paganin F; Ngo MT; Vandemoortele T; Anevlavis S; Froudarakis ME; Vergnon JM
Clin Respir J; 2017 Nov; 11(6):1006-1011. PubMed ID: 26789129
[TBL] [Abstract][Full Text] [Related]
12. De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival.
Cymerman RM; Shao Y; Wang K; Zhang Y; Murzaku EC; Penn LA; Osman I; Polsky D
J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27235387
[TBL] [Abstract][Full Text] [Related]
13. Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors.
Tas F; Erturk K
Melanoma Res; 2017 Apr; 27(2):134-139. PubMed ID: 28099368
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
Clemente CG; Mihm MC; Bufalino R; Zurrida S; Collini P; Cascinelli N
Cancer; 1996 Apr; 77(7):1303-10. PubMed ID: 8608507
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma.
Bedikian AY; Wei C; Detry M; Kim KB; Papadopoulos NE; Hwu WJ; Homsi J; Davies M; McIntyre S; Hwu P
Am J Clin Oncol; 2011 Dec; 34(6):603-10. PubMed ID: 21150567
[TBL] [Abstract][Full Text] [Related]
16. Primary dermal melanoma: distinct immunohistochemical findings and clinical outcome compared with nodular and metastatic melanoma.
Cassarino DS; Cabral ES; Kartha RV; Swetter SM
Arch Dermatol; 2008 Jan; 144(1):49-56. PubMed ID: 18209168
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and prognostic indicators for metastatic melanoma: data from 446 patients in north China.
Hao M; Zhao G; Du X; Yang Y; Yang J
Tumour Biol; 2016 Aug; 37(8):10339-48. PubMed ID: 26846098
[TBL] [Abstract][Full Text] [Related]
18. No correlation of tyrosinase mRNA in bone marrow with prognosis of metastatic melanoma.
Waldmann V; Wacker J; Deichmann M; Näher H
Dermatology; 2000; 201(1):6-9. PubMed ID: 10971051
[TBL] [Abstract][Full Text] [Related]
19. [Melanomas more serious in the elderly].
van der Meijden WA; van Bruchem-Visser RL; Thio HB; van der Cammen TJ
Ned Tijdschr Geneeskd; 2010; 154():A1535. PubMed ID: 20482904
[TBL] [Abstract][Full Text] [Related]
20. Prognosis associated with cutaneous melanoma metastases.
Pan Y; Haydon AM; McLean CA; McDonald PB; Kelly JW
Australas J Dermatol; 2015 Feb; 56(1):25-8. PubMed ID: 25688698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
